Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - Wiley Online Library
Low‐risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

[HTML][HTML] Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - ncbi.nlm.nih.gov
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - search.proquest.com
Low‐risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - europepmc.org
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer Medicine, 2015 - hero.epa.gov
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - search.ebscohost.com
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

[PDF][PDF] Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - cyberleninka.org
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …

[PDF][PDF] Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

C Bal, S Ballal, R Soundararajan, S Chopra, A Garg - Cancer Medicine, 2015 - Citeseer
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …